Comparing Outcomes of Patients with Secondary AML: Treatment-Related MDS/AML, AML Secondary to Myeloproliferative Neoplasms (t-MPN), and AML with Prior Malignancies
暂无分享,去创建一个
M. Konopleva | M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | A. Quintás-Cardama | F. Ravandi | G. Borthakur | S. Pierce | W. Wierda | S. Faderl | C. A. Yi